Skip to main content

Herpes Zoster Linked to Increased Long-Term Risk for Cognitive Decline

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 16, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Aug. 16, 2024 -- Herpes zoster (HZ) is associated with an increased long-term risk for subjective cognitive decline (SCD), according to a study published online Aug. 14 in Alzheimer's Research & Therapy.

Tian-Shin Yeh, M.D., Ph.D., from Taipei Medical University in Taiwan, and colleagues prospectively examined the association between HZ and subsequent SCD using data from 149,327 participants from the Nurses' Health Study (NHS), NHSII, and Health Professionals Follow-up Study (HPFS). The multivariable-adjusted relative risk (MVRR) of a 3-unit increment in the SCD score was estimated according to years since HZ compared to participants with no history of HZ.

The researchers found that the MVRR of a 3-unit increment in the SCD score was significantly and independently higher for individuals with a history of HZ versus those with no history of HZ, but the association varied with time since HZ. HZ was associated with a higher long-term risk for SCD in the NHS; the MVRR was 1.14 for a 3-unit increment in the SCD score for ≥13 years since HZ compared with no history of HZ. In NHSII, HZ was associated with a higher risk for SCD in the short and long term (MVRRs, 1.34 for one to four years and 1.20 for ≥13 years since HZ). An elevated risk for SCD was suggested across all time points in the HPFS. There was a suggestion that the association differed by APOE ε4 carrier status, but results were not consistent for men and women.

"The magnitude of the elevated long-term risk of SCD may potentially be reduced by HZ vaccination, but further study is needed," the authors write.

Several authors disclosed ties to pharmaceutical companies, including GlaxoSmithKline, which funded the study.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk

TUESDAY, April 29, 2025 -- An intensive blood pressure (BP) reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and...

32 Percent of Dementia Attributed to Audiometric Hearing Loss

MONDAY, April 28, 2025 -- The population attributable fraction of dementia from any audiometric hearing loss is 32.0 percent, according to a study published online April 17 in...

Moderately Preterm Birth Tied to Long-Term Cognitive Problems

FRIDAY, April 25, 2025 -- Moderately preterm birth is associated with cognitive problems at ages 9 to 10 years, according to a study published online April 14 in JAMA Network...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.